
Xtant Medical Investor Relations Material
Latest events

Q2 2025
Xtant Medical
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Xtant Medical Holdings Inc
Access all reports
Xtant Medical Holdings Inc develops and manufactures regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The Company's OsteoSponge biomaterial is a natural scaffold used to promote bone formation or repair. Its other products include OsteoStop, an autologous cell therapy that induces a pro-inflammatory response to reduce endothelial cell activation, OsteoSelect DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoFactor cream that contains various proteins and peptides that support bone formation and remodeling.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
XTNT
Country
🇺🇸 United States